SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-070593
Filing Date
2018-11-29
Accepted
2018-11-29 15:34:35
Documents
3
Period of Report
2019-01-15
Effectiveness Date
2018-11-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-40826_1def14a.htm DEF 14A 428971
2 GRAPHIC g408261bgi001.jpg GRAPHIC 6095
3 GRAPHIC g408261bci001.jpg GRAPHIC 4977
  Complete submission text file 0001104659-18-070593.txt   445576
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36856 | Film No.: 181208373
SIC: 2834 Pharmaceutical Preparations